Trehalose 6,6′-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice

American Journal of Pathology

Volumn 168, Issue 4, 2006, Pages 1249-1261

  Hunter, Robert L ^a,b   Olsen, Margaret ^a   Jagannath, Chinnaswamy ^a   Actor, Jeffrey K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORD FACTOR; FAT DROPLET; LIPID;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASEATING GRANULOMA; CONTROLLED STUDY; DISEASE MODEL; INFLAMMATION; LIPID STORAGE; LUNG ALVEOLUS; LUNG TUBERCULOSIS; MOUSE; MOUSE STRAIN; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 33645450141     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050848     Document Type: Article

References (81)

1. Brennan PJ, Nikaido H: The envelope of mycobacteria. Ann Rev Biochem 1995, 64:29-63
2. Yano I: The 72nd Annual Meeting Education Lecture. Cord factor. Kekkaku 1998, 73:37-42
3. Hunter RL, Venkatprasad N, Olsen M: The role of trehalose dimycolate (cord factor) in morphology of virulent M. tuberculosis in vitro. Tuberculosis (Edinb). 2005 Dec 9; [Epub ahead of print]
4. Ryll R, Kumazawa Y, Yano I: Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids - a review. Microbiol Immunol 2001, 45:801-811
5. Youmans GP: Mycobacterial lipids: chemistry and biologic activities. Tuberculosis. Edited by Youmans GP. Philadelphia, W.B. Saunders Co., 1979, pp 63-193
6. Perez RL, Roman J, Roser S, Little C, Olsen M, Indrigo J, Hunter RL, Actor JK: Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6′-dimycolate. J Interferon Cytokine Res 2000, 20:795-804
7. Bekierkunst A, Yarkoni E: Granulomatous hypersensitivity to trehalose-6,6′-dimycolate (cord factor) in mice infected with BCG. Infect Immun 1973, 7:631-638
8. Sugawara I, Udagawa T, Hua SC, Reza-Gholizadeh M, Otomo K, Saito Y, Yamada H: Pulmonary granulomas of guinea pigs induced by inhalation exposure of heat-treated BCG Pasteur, purified trehalose dimycolate and methyl ketomycolate. J Med Microbiol 2002, 51:131-137
9. Yamagami H, Matsumoto T, Fujiwara N, Arakawa T, Kaneda K, Yano I, Kobayashi K: Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice. Infect Immun 2001, 69:810-815
10. Silva CL, Ekizlerian SM, Fazioli RA: Role of cord factor in the modulation of infection caused by mycobacteria. Am J Pathol 1985, 118:238-247
11. Indrigo J, Hunter Jr RL, Actor JK: Cord factor trehalose 6,6′-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 2003, 149:2049-2059
12. Youmans GP: Biologic activities of mycobacterial cells and cell components. Tuberculosis. Edited by Youmans GP. Philadelphia, W.B. Saunders, 1979, pp 46-62
13. Retzinger GS, Meredith SC, Takayama K, Hunter RL, Kezdy FJ: The role of surface in the biological activities of trehalose 6,6′-dimycolate. Surface properties and development of a model system. J Biol Chem 1981, 256:8208-8216
14. Retzinger GS, Meredith SC, Hunter RL, Takayama K, Kezdy FJ: Identification of the physiologically active state of the mycobacterial glycolipid trehalose 6,6′-dimycolate and the role of fibrinogen in the biologic activities of trehalose 6,6′-dimycolate monolayers. J Immunol 1982, 129:735-744
15. Bloch H, Noll H: Studies on the virulence of tubercle bacilli. The effect of cord factor on murine tuberculosis. Br J Exp Pathol 1955, 36:8-17
16. Behling CA, Perez RL, Kidd MR, Staton GJ, Hunter RL: Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids. Ann Clin Lab Sci 1993, 23:256-266
17. Syed SS, Hunter RL: Studies on the toxic effects of quartz and a mycobacterial glycolipid, trehalose 6,6′-dimycolate. Ann Clin Lab Sci 1997, 27:375-383
18. Behling CA, Bennett B, Takayama K, Hunter RL: Development of a trehalose 6,6′-dimycolate model which explains cord formation by Mycobacterium tuberculosis. Infect Immun 1993, 61:2296-2303
19. Schabbing RW, Garcia A, Hunter RL: Characterization of the trehalose 6,6′-dimycolate surface monolayer by scanning tunneling microscopy. Infect Immun 1994, 62:754-756
20. Goren M: Cord factor revisited: a tribute to the late Hubert Bloch. Tubercle 1975, 56:65-71
21. Dannenberg Jr AM, Collins FM: Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis (Edinb) 2001, 81:229-242
22. North RJ, Jung YJ: Immunity to tuberculosis. Annu Rev Immunol 2004, 22:599-623
23. Pagel W, Simmonds F, MacDonald N, Nassau E: The morbid anatomy and histology of tuberculosis, an introduction in simple terms. Pulmonary Tuberculosis, Bacteriology, Pathology, Management, Epidemiology and Prevention. London, Oxford University Press, 1964, pp 36-63
24. Florey H: Tuberculosis. General pathology based on lectures delivered at the Sir William Dunn School of Pathology, University of Oxford. Philadelphia, W.B Saunders, 1958, pp 829-870
25. Levine ER: Classification of reinfection pulmonary tuberculosis. The Fundamentals of Pulmonary Tuberculosis and its Complications. Edited by Hayes E. Springfield, Charles C. Thomas, 1949, pp 97-113
26. Gunn FD: Tuberculosis. Pathology, ed 4. Edited by Anderson WAD. St. Louis, C.V. Mosby Company, 1961, pp 243-263
27. Uygur-Bayramicli O, Dabak G, Dabak R: A clinical dilemma: abdominal tuberculosis. World J Gastroenterol 2003, 9:1098-1101
28. Tandon HD, Prakash A: Pathology of intestinal tuberculosis and its distinction from Crohn's disease. Gut 1972, 13:260-269
29. Mustafa T, Phyu S, Nilsen R, Jonsson R, Bjune G: A mouse model for slowly progressive primary tuberculosis. Scand J Immunol 1999, 50:127-136
30. Pagel W, Pagel W: Zur Histochemie der Lungentuberkulose, mit besonderer Berucksichtung der Fettsubstanzen und Lipoide. (Fat and lipoid content to tuberculous tissue. Histochemical investigation.). Virchows Arch Pathol Anat 1925, 256:629-640
31. Cardona PJ, Gordillo S, Diaz J, Tapia G, Amat I, Pallares A, Vilaplana C, Ariza A, Ausina V: Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis. Infect Immun 2003, 71:5845-5854
32. Bloch H: Studies on the virulence of tubercle bacilli: isolation and biological properties of a constituent of virulent organisms. J Exp Med 1950, 91:197-219
33. Pierce C: Infection of mice with mammalian tubercle bacilli grown in Tween-albumin medium. J Exp Med 1947, 86:159-174
34. Watson VE, Hill LL, Owen-Schaub LB, Davis DW, McConkey DJ, Jagannath C, Hunter Jr RL, Actor JK: Apoptosis in Mycobacterium tuberculosis infection in mice exhibiting varied immunopathology. J Pathol 2000, 190:211-220
35. Guidry TV, Olsen M, Kil KS, Hunter Jr RL, Geng YJ, Actor JK: Failure of CD1D-/- mice to elicit hypersensitive granulomas to mycobacterial cord factor trehalose 6,6′-dimycolate. J Interferon Cytokine Res 2004, 24:362-371
36. Bekierkunst A, Levij IS, Yarkoni E, Vilkas E, Adam A, Lederer E: Granuloma formation induced in mice by chemically defined mycobacterial fractions. J Bacteriol 1969, 100:95-102
37. Dvorak HF, Galli SJ, Dvorak AM: Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol 1986, 17:122-137
38. Dannenberg Jr AM: Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. Immunobiology 1994, 191:461-473
39. Lefford ML: Diseases in mice and rats. The Mycobacteria: A Source-book. Edited by Wayne G.K.AL. New York, Marcel Dekker, 1984, pp 947-977
40. Garay S: Pulmonary tuberculosis. Tuberculosis. Edited by Garay W.R.S. Boston, Little Brown & Co, 1996, pp 373-412
41. Yoder M, Lamichhane G, Bishai W: Cavitary pulmonary tuberculosis: the Holy Grail of disease transmission. Curr Sci 2004, 86:74-81
42. Bekierkunst A: Acute granulomatous response produced in mice by trehalose-6,6-dimycolate. J Bacteriol 1968, 96:958-961
43. Indrigo J, Hunter Jr RL, Actor JK: Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 2002, 148:1991-1998
44. Ridley DS, Ridley MJ: Rationale for the histological spectrum of tuberculosis. A basis for classification. Pathology 1987, 19:186-192
45. Grosset J: Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob Agents Chemother 2003, 47:833-836
46. Dannenburg A: Pathophysiology: basic aspects. Tuberculosis and nontuberculous mycobacterial infections, ed 4. Edited by Schlossberg D. Philadelphia, W.B. Saunders, 1999, pp 26-27
47. Smith I, Nathan C, Peavy HH, NHLBI Working Group: Progress and new directions in genetics of tuberculosis. Am J Respir Crit Care Med 2005, 172:1491-1496
48. Ehlers S, Benini J, Held HD, Roeck C, Alber G, Uhlig S: Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J Exp Med 2001, 194:1847-1859
49. Perez RL, Roman J, Staton GJ, Hunter RL: Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6′-dimycolate. Am J Respir Crit Care Med 1994, 149:510-518
50. Sugawara I, Yamada H, Kazumi Y, Doi N, Otomo K, Aoki T, Mizuno S, Udagawa T, Tagawa Y, Iwakura Y: Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis. J Med Microbiol 1998, 47:871-877
51. Catel W, Schmidt W: Klinische und experimetelle untersuchunge uber das wessen der lokalen tuberkulin empfindlichkeit. Deut Med Wochenschr 1950, 75:1140
52. Moody DB, Guy MR, Grant E, Cheng TY, Brenner MB, Besra GS, Porcelli SA: CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med 2000, 192:965-976
53. Ulrichs T, Moody DB, Grant E, Kaufmann SH, Porcelli SA: T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect Immun 2003, 71:3076-3087
54. Cohen C: Tuberculous mastitis. A review of 34 cases. S Afr Med J 1977, 52:12-14
55. Dent DM, Webber BL: Tuberculosis of the breast. S Afr Med J 1977, 51:611-614
56. Jordaan HF, Schneider JW, Abdulla EA: Nodular tuberculid: a report of four patients. Pediatr Dermatol 2000, 17:183-188
57. Kumar R, Kapoor D, Singh J, Kumar N: Isolated tuberculosis of the pancreas: a report of two cases and review of the literature. Trop Gastroenterol 2003, 24:76-78
58. Medlar E: A study of the process of caseation in tuberculosis. Am J Pathol 1926, 2:275-290
59. Jayasundar R, Singh VP, Raghunathan P, Jain K, Banerji AK: Inflammatory granulomas: evaluation with proton MRS. NMR Biomed 1999, 12:139-144
60. Birkun AA: Disorders of fat metabolism in the lungs in tuberculosis. Pathomorphological and histochemical characteristics. Arkh Patol 1963, 25:23-32
61. Mauss H, Levy FM: Involvement of adipose tissue in experimental tuberculosis of the mouse. Pathol Microbiol (Basel) 1972, 38:333-345
62. Hamamoto Y, Kobara Y, Kojima A, Kumazawa Y, Yasuhira K: Experimental production of pulmonary granulomas. I. Immune granulomas induced by chemically modified cell walls and their constituents. Br J Exp Pathol 1981, 62:259-269
63. Yamamura Y, Maeda H, Ogawa Y, Hashimoto T: Experimental pulmonary cavity formation by mycobacterial components and synthetic adjuvants. Microbiol Immunol 1986, 30:1175-1187
64. Maeda H, Yamamura Y, Ogawa Y, Maeda J: Mycobacterial antigens relating to experimental pulmonary cavity formation. Am Rev Respir Dis 1977, 115:617-623
65. Khomenko AG, Golyshevskaia VI: Model of destructive tuberculosis in guinea pigs. Biull Eksp Biol Med 1981, 92:627-629
66. Bloch H: Bacterial components concerned in the early phase of infection. CIBA Foundation Symposium on Experimental Tuberculosis. Edited by G.E.W. Wolstenholme, M.P. Cameron, C. O'Conner. Boston, Little Brown & Co., 1955, pp 131-137
67. Lurie M: The correlation between the histological changes and the fate of living tubercle bacilli in the organs of tuberculous rabbits. J Exp Med 1932, 55:31-54
68. Lurie M, Abramson S, Heppleston A: On the response of genetically resistant and susceptible rabbits to the quantitative inhalation of human type tubercle bacilli and the nature of resistance to tuberculosis. J Exp Med 1952, 95:119-135
69. Pedrosa J, Saunders BM, Appelberg R, Orme IM, Silva MT, Cooper AM: Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun 2000, 68:577-583
70. Sugawara I, Udagawa T, Yamada H: Rat neutrophils prevent the development of tuberculosis. Infect Immun 2004, 72:1804-1806
71. Dunn PL, North RJ: Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology. J Med Microbiol 1996, 45:103-109
72. Korf J, Stoltz A, Verschoor J, De Baetselier P, Grooten J: The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur J Immunol 2005, 35:890-900
73. Chimote G, Banerjee R: Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity. Colloids Surf B Biointerfaces 2005, 45:215-223
74. Riviere M, Moisand A, Lopez A, Puzo G: Highly ordered supramolecular organization of the mycobacterial lipoarabinomannans in solution. Evidence of a relationship between supra-molecular organization and biological activity. J Mol Biol 2004, 344:907-918
75. Ferguson JS, Voelker DR, Ufnar JA, Dawson AJ, Schlesinger LS: Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J Immunol 2002, 168:1309-1314
76. Pasula R, Wright JR, Kachel DL, Martin II WJ: Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J Clin Invest 1999, 103:483-490
77. Daffe M, Draper P: The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microbial Physiol 1998, 39:131-203
78. Goren MB, Brennan PJ: Mycobacterial lipids: chemistry and biologic activities. Tuberculosis. Edited by Youmans GP. Philadelphia, W.B. Saunders, 1979, pp 63-193
79. Rao V, Fujiwara N, Porcelli SA, Glickman MS: Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 2005, 201:535-543
80. Bloch H: Virulence of mycobacteria. Adv Tuberc Res 1955, 6:49-61
81. Geisel RE, Sakamoto K, Russell DG, Rhoades ER: In vivo activity of released cell wall lipids of Mycobacterium bovis Bacillus Calmette-Guerin is due principally to trehalose mycolates. J Immunol 2005, 174:5007-5015